REalWorld Insights on the INitiation and Treatment Duration of ticagrEloR & Other Oral Antiplatelets (OAP) in Patients With Acute Coronary Syndrome (ACS) in Be/Lux.

Clinical trial NCT02190123 · COMPLETED

Trial details

NCT number: NCT02190123
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Treatment of Acute Coronary Syndrome (ACS).

Start date: 2014-09-01
Primary completion: 2015-01-01
Enrollment: 430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.